Elicio Therapeutics Inc. (ELTX) earnings · rev $2.3M
These earnings events as JSON? API free 100/dayElicio Therapeutics Inc. (ELTX) is a biotechnology company listed on US.
This ELTX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ELTX revenue for 2022-12-31 was $2.3M. Net income was -$38.8M. ELTX currently screens at market cap $132.3M.
When the next ELTX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for ELTX. We will not invent a beat or miss.
Not investment advice. Full ELTX research stays on the stock page; the tape stays on the quote page.
ELTX earnings FAQ
What are ELTX's latest revenue and net income?
Latest cached Elicio Therapeutics Inc. (ELTX) revenue for Dec 31, 2022 was $2.3M. Net income was -$38.8M. Statements: https://lician.com/financials/eltx
What is ELTX's latest diluted EPS?
Latest cached Elicio Therapeutics Inc. (ELTX) diluted EPS for Dec 31, 2022 was -$1.29.
What period does the latest ELTX earnings print cover?
The latest cached Elicio Therapeutics Inc. (ELTX) earnings print covers Dec 31, 2022.
Where are ELTX earnings listed?
Cached earnings facts for Elicio Therapeutics Inc. (ELTX) are listed at https://lician.com/earnings/eltx. Statements: https://lician.com/financials/eltx
Not investment advice.